Joshua Brumm, COO & CFO at Aravive, holds 201.27K shares in Aravive (Ticker: ARAV), holds ― shares in Kaleido Biosciences (Ticker: KLDO), holds 538.00K shares in Dyne Therapeutics (Ticker: DYN). Most recently, Joshua Brumm Sold ― shares of Aravive on Oct 23, 2017 for an estimated value of 3.38K.
Joshua Brumm latest transaction was an Informative Sell of $3.38K.
What was Joshua Brumm's most profitable transaction?
Joshua Brumm’s most profitable transaction was an Informative Sell of ARAV stock on January 31, 2017. The return on the trade was 86.00%.
What is Joshua Brumm's role in Aravive?
Joshua Brumm's role in Aravive is COO & CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.